Company intelligence / Profile preview

Rocky Mountain Cancer Centers

Denver, Colorado, USArockymountaincancercenters.com ↗

Ownership: Private
Development stage: Commercial

Overview

Rocky Mountain Cancer Centers provides comprehensive outpatient oncology services across Colorado. It offers chemotherapy, immunotherapy, hormone therapy, radiation therapy, targeted therapies, access to over 500 active clinical trials via partnerships with Sarah Cannon Research Institute and The US Oncology Network. Clinical results are consistent with national standards for community-based oncology practices. No proprietary drug development or pipeline.

Therapeutic areas: OncologyHematology
Modalities: Small moleculeBiologicHormoneRadiation therapyTargeted therapy
Industry: Non-Academic Healthcare

Partnerships

Sarah Cannon Research InstituteThe US Oncology NetworkMcKesson Specialty HealthNCCN Value Pathways collaboration

Beyond the preview

Go deeper on Rocky Mountain Cancer Centers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rocky Mountain Cancer Centers.

Explore the full profile